Cochrane Abstracts
Cannabinoids for the treatment of dementia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cannabinoids for the Treatment of Dementia." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431007/all/Cannabinoids_for_the_treatment_of_dementia.
Cannabinoids for the treatment of dementia. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431007/all/Cannabinoids_for_the_treatment_of_dementia. Accessed November 22, 2024.
Cannabinoids for the treatment of dementia. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431007/all/Cannabinoids_for_the_treatment_of_dementia
Cannabinoids for the Treatment of Dementia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431007/all/Cannabinoids_for_the_treatment_of_dementia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cannabinoids for the treatment of dementia
ID - 431007
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431007/all/Cannabinoids_for_the_treatment_of_dementia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
